BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO)

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Class B Common Stock
Shares outstanding
5,071,025
Total 13F shares
18,786,490
Share change
-93,641
Total reported value
$6,730,924,381
Put/Call ratio
109%
Price per share
$358.45
Number of holders
466
Value change
-$58,698,141
Number of buys
194
Number of sells
239

Institutional Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q3 2023

As of 30 Sep 2023, BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) was held by 466 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,786,490 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., Veritas Asset Management LLP, BROWN ADVISORY INC, STATE STREET CORP, UBS ASSET MANAGEMENT AMERICAS INC, BANK OF AMERICA CORP /DE/, GEODE CAPITAL MANAGEMENT, LLC, ALLIANCEBERNSTEIN L.P., and MILLENNIUM MANAGEMENT LLC. This page lists 466 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.